Rare Diseases Symptoms Automatic Extraction
Home
A random Abstract
Our Project
Our Team
A patient with an inborn error of vitamin B12 metabolism (cblF) detected by newborn screening.
[homocystinuria without methylmalonic aciduria]
A
neonate
,
who
was
found
to
have
an
elevated
C
3
/
C
2
ratio
and
minimally
elevated
propionylcarnitine
on
newborn
screening
,
was
subsequently
identified
as
having
the
rare
cblF
inborn
error
of
vitamin
B
12
(
cobalamin
)
metabolism
.
This
disorder
is
characterized
by
the
retention
of
unmetabolized
cobalamin
in
lysosomes
such
that
it
is
not
readily
available
for
cellular
metabolism
.
Although
cultured
fibroblasts
from
the
patient
did
not
show
the
expected
functional
abnormalities
of
the
cobalamin-dependent
enzymes
,
methylmalonyl-
CoA
mutase
and
methionine
synthase
,
they
did
show
reduced
synthesis
of
the
active
cobalamin
cofactors
adenosylcobalamin
and
methylcobalamin
.
Mutation
analysis
of
LMBRD
1
established
that
the
patient
had
the
cblF
disorder
.
Treatment
was
initiated
promptly
,
and
the
patient
showed
a
robust
response
to
regular
injections
of
cyanocobalamin
,
and
she
was
later
switched
to
hydroxocobalamin
.
Currently
,
at
3
years
of
age
,
the
child
is
clinically
well
,
with
appropriate
development
.
Adjusted
newborn
screening
cutoffs
in
Ontario
allowed
detection
of
a
deficiency
that
might
not
have
otherwise
been
identified
,
allowing
early
treatment
and
perhaps
preventing
the
adverse
sequelae
seen
in
some
untreated
patients
.
Diseases
Validation
Diseases presenting
"early treatment"
symptom
acute rheumatic fever
allergic bronchopulmonary aspergillosis
benign recurrent intrahepatic cholestasis
cowden syndrome
fabry disease
familial mediterranean fever
homocystinuria without methylmalonic aciduria
kallmann syndrome
krabbe disease
omenn syndrome
phenylketonuria
pyomyositis
scrub typhus
You can validate or delete this automatically detected symptom
Validate the Symptom
Delete the Symptom